Versatile phototheranostic system: Aza-BODIPY-based nanoparticles with B,O-chelated core and diiodine
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Chemotherapy: a double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
2. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
3. NIR-II organic nanotheranostics for precision oncotherapy10.1002/smll.202102646 ↗
4. Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications10.1021/jacs.0c07022 ↗
5. In vivo dissolution of poorly water-soluble drugs: proof of concept based on fluorescence bioimaging10.1016/j.apsb.2020.08.002 ↗
6. Recent advances in contrast-enhanced photoacoustic imaging: overcoming the physical and practical challenges10.1021/acs.chemrev.2c00627 ↗
7. Recent advances of smart AIRgens for photoacoustic imaging and phototherapy10.1016/j.ccr.2022.214725 ↗
8. Recent progress in near-infrared photoacoustic imaging10.1016/j.bios.2021.113478 ↗
9. Activatable molecular agents for cancer theranostics10.1039/C9SC05460J ↗
10. Recent developments in multimodality fluorescence imaging probes10.1016/j.apsb.2018.03.010 ↗
11. Near infrared (NIR) absorbing dyes as promising photosensitizer for photo dynamic therapy10.1016/j.ccr.2020.213233 ↗
12. Photothermal-based nanomaterials and photothermal-sensing: an overview10.1016/j.bios.2022.114883 ↗
13. Photodynamic-based combinatorial cancer therapy strategies: tuning the properties of nanoplatform according to oncotherapy needs10.1016/j.ccr.2022.214495 ↗
14. BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment10.1021/jacs.2c11650 ↗
15. Solutions to the drawbacks of photothermal and photodynamic cancer therapy10.1002/advs.202002504 ↗
16. Aza-BODIPY probe-decorated mesoporous black tio2 nanoplatform for the highly efficient synergistic phototherapy10.1021/acsami.0c10531 ↗
17. 2-pyridone-functionalized aza-BODIPY photosensitizer for imaging-guided sustainable phototherapy10.1016/j.biomaterials.2018.08.034 ↗
18. Mitochondria-targeting phototheranostics by aggregation-induced NIR-II emission luminogens: modulating intramolecular motion by electron acceptor engineering for multi-modal synergistic therapy10.1002/adfm.202110526 ↗
19. NIR-II phototherapy agents with aggregation-induced emission characteristics for tumor imaging and therapy10.1016/j.biomaterials.2022.121535 ↗
20. Bioapplications of small molecule aza-BODIPY: from rational structural design to in vivo investigations10.1039/D0CS00234H ↗
21. Basic structural modifications for improving the practical properties of BODIPY10.1016/j.ccr.2022.214684 ↗
22. Aza-BODIPY-based nanomedicines in cancer phototheranostics10.1021/acsami.0c05021 ↗
23. Boosting O2•− photogeneration via promoting intersystem-crossing and electron-donating efficiency of aza-BODIPY-based nanoplatforms for hypoxic-tumor photodynamic therapy10.1002/smtd.202000013 ↗
24. A bright, renal-clearable NIR-II brush macromolecular probe with long blood circulation time for kidney disease bioimaging10.1002/anie.202114273 ↗
25. Aza-BODIPY encapsulated polymeric nanoparticles as an effective nanodelivery system for photodynamic cancer treatment10.1039/D0QM00891E ↗
26. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
27. Recent advances in photonanomedicines for enhanced cancer photodynamic therapy10.1016/j.pmatsci.2020.100685 ↗
28. Reexamining the heavy-atom-effect: the universal heavy-atom-induced fluorescence enhancement principle for through-space conjugated AIEgens10.1016/j.cej.2022.139030 ↗
29. Breaking classic heavy-atom effect to achieve heavy-atom-induced dramatic emission enhancement of silole-based AIEgens with through-bond and through-space conjugation10.1002/adom.202101228 ↗
30. BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect10.1021/acsami.7b07569 ↗
31. Phototherapy and optical waveguides for the treatment of infection10.1016/j.addr.2021.114036 ↗
32. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
33. Precise molecular engineering of small organic phototheranostic agents toward multimodal imaging-guided synergistic therapy10.1021/acsnano.1c00585 ↗
34. Rigidity bridging flexibility to harmonize three excited-state deactivation pathways for NIR-II-fluorescent-imaging-guided phototherapy10.1002/adhm.202101003 ↗
35. Regulating the photophysical property of organic/polymer optical agents for promoted cancer phototheranostics10.1002/adma.201806331 ↗
36. Conformationally restricted and ring-fused aza-BODIPYs as promising near infrared absorbing and emitting dyes10.1016/j.ccr.2022.214709 ↗
37. Near-infrared absorbing (>700 nm) aza-BODIPYs by freezing the rotation of the aryl groups10.1016/j.cclet.2021.06.083 ↗
38. Molecular engineering of near-infrared light-responsive BODIPY-based nanoparticles with enhanced photothermal and photoacoustic efficiencies for cancer theranostics10.7150/thno.34418 ↗
39. A facile, protein-derived supramolecular theranostic strategy for multimodal-imaging-guided photodynamic and photothermal immunotherapy in vivo10.1002/adma.202109111 ↗
40. Nitric oxide imaging in cancer enabled by steric relaxation of a photoacoustic probe platform10.1039/C9SC05600A ↗
41. Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy10.1039/D0NH00672F ↗
42. Donor/π-bridge manipulation for constructing a stable NIR-II aggregation-induced emission luminogen with balanced phototheranostic performance10.1002/anie.202111767 ↗
43. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
44. Photosensitizers for photodynamic therapy10.1002/adhm.201900132 ↗
45. AIE bioconjugates for biomedical applications10.1002/adom.202000162 ↗
46. All-in-one theranostic platforms: deep-red AIE nanocrystals to target dual-organelles for efficient photodynamic therapy10.1021/acsnano.2c04465 ↗
47. Type I photosensitizers revitalizing photodynamic oncotherapy10.1002/smll.202006742 ↗
48. Precise molecular engineering of type i photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria10.1002/advs.202104079 ↗
49. Dual-step irradiation strategy to sequentially destroy singlet oxygen-responsive polymeric micelles and boost photodynamic cancer therapy10.1016/j.biomaterials.2021.120959 ↗
50. Covalent organic framework nanocarriers of singlet oxygen for oxygen-independent concurrent photothermal/photodynamic therapy to ablate hypoxic tumors10.1002/smll.202202369 ↗
51. Tailored engineering of novel xanthonium polymethine dyes for synergetic PDT and PTT triggered by 1064 nm laser toward deep-seated tumors10.1002/smll.202100398 ↗
52. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT10.1021/acsnano.1c10019 ↗
53. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers10.1016/j.addr.2020.06.005 ↗
54. Cationization to boost both type I and type II ros generation for photodynamic therapy10.1016/j.biomaterials.2021.121255 ↗
55. Indocyanine green assembled free oxygen-nanobubbles towards enhanced near-infrared induced photodynamic therapy10.1007/s12274-022-4085-0 ↗
56. Aza-BODIPY-based phototheranostic nanoagent for tissue oxygen auto-adaptive photodynamic/photothermal complementary therapy10.1007/s12274-021-3552-3 ↗